低强度光疗对中度创伤性脑损伤患者磁共振波谱代谢物的影响:一项双盲、随机、安慰剂对照临床试验
本研究为前瞻性单中心双盲假对照试验的二次分析,纳入34例中度创伤性脑损伤患者(15例低强度光疗,19例假治疗),采用3T二维磁共振波谱成像评估胼胝体代谢物。假治疗组mIns/NAA从急性期至晚期亚急性期显著升高(0.19;95%CI 0.09-0.29;P Holm=0.005),而低强度光疗组保持稳定;晚期亚急性期假治疗组mIns/NAA显著高于低强度光疗组(-0.31;95%CI -0.50至-0.12;P Holm=0.019)。作者认为低强度光疗可能具有神经保护和抗炎作用。
要点
- 假治疗组胼胝体mIns/NAA从急性期至晚期亚急性期显著升高,低强度光疗组保持稳定。
- 晚期亚急性期假治疗组mIns/NAA显著高于低强度光疗组。
- 作者认为急性期低强度光疗可能具有神经保护和抗炎作用。
核心结论
- 尽管样本量小,磁共振波谱成像显示接受低强度光疗的中度创伤性脑损伤患者与假治疗组相比存在代谢反应,可能提示急性期低强度光疗具有神经保护和抗炎作用。
研究设计与样本
- 前瞻性单中心双盲假对照研究的二次分析,最终数据集纳入34例中度创伤性脑损伤患者(18例男性,年龄49±17岁,范围20-79岁;15例低强度光疗,19例假治疗),采用3T二维磁共振波谱成像,于急性期(1周内,n=24)、亚急性期(2-3周,n=27)和晚期亚急性期(3个月,n=23)扫描。
诊断标准与关键数值
- 感兴趣区为胼胝体,分析指标为mIns/NAA比值,代表神经炎症升高(mIns)与神经元/轴突健康下降(NAA)的综合效应。
- 假治疗组mIns/NAA从急性期至晚期亚急性期显著升高(0.19;95%CI 0.09-0.29;P Holm=0.005)。
- 低强度光疗组mIns/NAA保持相对稳定(所有P Holm>0.64)。
- 晚期亚急性期假治疗组mIns/NAA显著高于低强度光疗组(-0.31;95%CI -0.50至-0.12;P Holm=0.019)。
局限性
- 原文指出样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Low-level light therapy (LLLT) has been shown to modulate recovery in patients with traumatic brain injury (TBI). However, the longitudinal impact of LLLT on brain metabolites has not been studied. The purpose of this study was to use MR spectroscopic imaging to assess the metabolic response of LLLT in patients with moderate TBI at acute (within 1 week), subacute (2-3 weeks), and late-subacute (3 months) recovery phases.
MATERIALS AND METHODS: This is a secondary analysis of a prospective single-site double-blind sham-controlled study conducted in patients with moderate TBI. Participants were randomized for LLLT and sham treatment. Three-Tesla 2D MR spectroscopic imaging was acquired. Our focus of investigation was the metabolic change in the corpus callosum (CC) and the changes in mIns/NAA, representing the combined effect of elevated neuroinflammation (mIns) and decreased neuronal/axonal health (NAA). A linear mixed-effects model was constructed to quantify the association between mIns/NAA and treatment, scan, and the interaction between treatment and scan.
RESULTS: Thirty-four participants (18 men, age 49 ± 17 [range, 20-79]; 15 LLLT, 19 sham) were included in the final data set and were scanned at the following time points: acute (n=24), subacute (n=27), and late subacute (n=23). The mIns/NAA ratio in the CC of the sham-treated participants increased over time. Sham-treated participants revealed a significant increase in mIns/NAA from the acute to the late subacute phases (0.19; 95% CI, 0.09-0.29; P Holm = .005). mIns/NAA stayed relatively stable in participants undergoing LLLT treatment (all P Holm > .64). Consequently, mIns/NAA was significantly higher in the sham-treated participants compared with the LLLT-treated participants during the late subacute phase of recovery (-0.31; 95% CI, -0.50 to -0.12; P Holm = .019).
CONCLUSIONS: Despite the small sample size, MR spectroscopic imaging indicates a metabolic response in participants treated with LLLT compared with those receiving sham treatment. This potentially suggests a neuroprotective and anti-inflammatory effect from the acute administration of LLLT in individuals with moderate TBI.
引用
- Ratai EM, Wenke MR, Mercaldo N, et al. Low-Level Light Therapy Effect on Metabolites Measured by MR Spectroscopy in Patients with Moderate Traumatic Brain Injury: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. AJNR Am J Neuroradiol. 2026. PMID: 40925680. doi:10.3174/ajnr.A8996
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。